Providence Capital Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.83M Buy
157,805
+42,012
+36% +$1.02M 0.7% 56
2025
Q1
$2.93M Buy
115,793
+1,435
+1% +$36.4K 0.61% 70
2024
Q4
$3.03M Buy
114,358
+409
+0.4% +$10.9K 0.62% 65
2024
Q3
$3.3M Buy
113,949
+806
+0.7% +$23.3K 0.65% 65
2024
Q2
$3.17M Buy
113,143
+1,855
+2% +$51.9K 0.69% 59
2024
Q1
$3.09M Buy
111,288
+29,379
+36% +$815K 0.67% 63
2023
Q4
$2.36M Sell
81,909
-4,637
-5% -$133K 0.57% 70
2023
Q3
$2.87M Sell
86,546
-64,466
-43% -$2.14M 0.75% 60
2023
Q2
$5.54M Buy
151,012
+900
+0.6% +$33K 1.41% 21
2023
Q1
$6.12M Buy
150,112
+3,148
+2% +$128K 1.62% 8
2022
Q4
$7.53M Buy
146,964
+1,215
+0.8% +$62.2K 2.03% 5
2022
Q3
$6.38M Buy
145,749
+360
+0.2% +$15.8K 1.91% 5
2022
Q2
$7.62M Sell
145,389
-16,358
-10% -$858K 2.22% 4
2022
Q1
$8.36M Buy
161,747
+10,996
+7% +$568K 2.05% 5
2021
Q4
$8.9M Sell
150,751
-7,914
-5% -$467K 2.45% 4
2021
Q3
$6.82M Buy
158,665
+9,987
+7% +$430K 2.13% 7
2021
Q2
$5.82M Buy
148,678
+4,078
+3% +$160K 1.88% 11
2021
Q1
$5.24M Sell
144,600
-887
-0.6% -$32.1K 1.9% 8
2020
Q4
$5.36M Buy
145,487
+10,510
+8% +$387K 2.19% 5
2020
Q3
$4.7M Buy
134,977
+351
+0.3% +$12.2K 2.48% 7
2020
Q2
$4.18M Sell
134,626
-2,317
-2% -$71.9K 2.37% 6
2020
Q1
$4.24M Buy
136,943
+39,148
+40% +$1.21M 2.55% 6
2019
Q4
$3.64M Buy
97,795
+1,076
+1% +$40K 1.95% 7
2019
Q3
$3.3M Buy
96,719
+14,988
+18% +$511K 1.94% 6
2019
Q2
$3.36M Buy
81,731
+2,368
+3% +$97.3K 1.99% 6
2019
Q1
$3.2M Buy
79,363
+1,619
+2% +$65.2K 2.01% 5
2018
Q4
$3.22M Sell
77,744
-10,414
-12% -$431K 2.21% 4
2018
Q3
$3.69M Sell
88,158
-12,616
-13% -$527K 2.41% 4
2018
Q2
$3.47M Buy
100,774
+3,648
+4% +$126K 2.43% 4
2018
Q1
$3.27M Buy
97,126
+5,248
+6% +$177K 2.45% 3
2017
Q4
$3.16M Buy
+91,878
New +$3.16M 2.44% 4